Migraine researchers and clinicians are growing excited about a new class of drugs called Calcitonin Gene-Related Peptide (CGRP) monoclonal antibodies, which are showing promise in treating high-frequency episodic migraine and chronic migraine. A release from the American Headache Society quotes Peter J. Goadsby, MD, PhD, chair of the scientific program of the American Headache Society’s… Continue reading Hope for New Migraine Prevention Drugs